• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » FDA issues EUA for Sterilucent N95 hydrogen peroxide sterilization

FDA issues EUA for Sterilucent N95 hydrogen peroxide sterilization

April 22, 2020 By Sean Whooley

The FDA has granted Sterilucent emergency use authorization (EUA) for its hydrogen peroxide sterilizer for use with N95 and N95-equivalent respirators — the latest in a string of mask sterilizers receiving EUAs amid the coronavirus pandemic.

Minneapolis-based Sterilucent’s HC 80TT vaporized hydrogen peroxide sterilizer may now be used to decontaminate the single-use compatible respirators that are in high demand among health providers treating people with COVID-19. 3M (NYSE:MMM) develops the N95 masks, while Owens & Minor (NYSE:OMI) and Honeywell (NYSE:HON) are also producing the respirators on U.S. Defense Dept. contracts.

3M has a technical bulletin that offers guidelines for decontaminating N95 respirators, including systems acceptable for mask reprocessing, and it includes the Sterilucent HC 80TT sterilizer, according to a news release.

Test results showed that filtering facepiece respirators may be reprocessed up to 10 times in the HC 80TT flexible cycle without a detrimental impact on performance or a reduction in respirator fit. The system is capable of reprocessing up to 12 respirators at one time.

In the release, Sterilucent COO Stephen Loes said the HC 80TT system uses the company’s Cycle Guardian technology to adjust the delivery of the sterilant based on the load in the chamber. Because the N95 load is light, the system delivers less chemistry, resulting in less degradation and lowering the cost per cycle, Loes said.

“We are glad to be able to help extend the safe use of PPE for healthcare staff during this time of overburdened supply chains,” Loes said. “The HC 80TT sterilizer can provide timely internal turnaround of PPE that helps extend a facility’s inventory and better manage supply disruption or unavailability.”

Last month, the DoD awarded a $415 million contract to provide 60 Battelle Critical Care Decontamination Systems that use vaporized hydrogen peroxide (VHP) to decontaminate as many as 80,000 N95 respirator masks each day for reuse.

Steris (NYSE:STE) gained EUA from the FDA earlier this month to use its own vaporized hydrogen peroxide system for N95 mask decontamination, as did Advanced Sterilization Products. Stryker (NYSE:SYK) also received EUA for decontaminating N95 masks with its Sterizone VP4 sterilizer, another hydrogen peroxide sterilizer.

Fresenius (NYSE:FMS) Helios announced today that it developed a process for sterilizing protective masks for reuse, employing the process for FFP2 and FFP3-type masks. In a news release, the company said Helios Germany’s hospitals can purify 8,000 masks daily, starting immediately. Fresenius opted not to commercialize the process and is offering information online, free of charge.

Filed Under: Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Respiratory, Sterilization / Calibration Tagged With: Advanced Sterilization Products, Battelle, coronavirus, FDA, Fresenius, Sterilucent Inc., Steris Corp., Stryker

More recent news

  • AiM Medical Robotics’ $2M NIH grant and other extra medtech news
  • Intuitive draws on data from 14M cases to back da Vinci systems
  • Ropca wins FDA clearance for ultrasound automation systems
  • Zimmer Biomet lets go of former Nevro CEO amid leadership restructuring
  • Petal Surgical says its first-in-human incisionless surgery is coming soon and offers a first glimpse of its system

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy